BRIEF published on 03/24/2026 at 21:35, 1 month 5 days ago DBV Technologies Joins CAC Mid 60 and SBF 120 Indices Biopharmaceutical SBF 120 DBV Technologies CAC Mid 60 VIASKIN®
PRESS RELEASE published on 03/24/2026 at 21:30, 1 month 5 days ago DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review DBV Technologies joins CAC Mid 60 and SBF 120 indices on Euronext Paris, increasing visibility among investors. Company focuses on food allergy treatments using VIASKIN patch technology Euronext Paris SBF 120 DBV Technologies Food Allergies CAC Mid 60
BRIEF published on 03/04/2026 at 22:35, 1 month 25 days ago DBV Technologies will participate in investor conferences in March Investor Conferences Biopharmaceutical DBV Technologies March 2026 Citizens Life Sciences
BRIEF published on 03/04/2026 at 22:35, 1 month 25 days ago DBV Technologies Announces Participation in March Investor Conferences Investor Conferences Biopharmaceutical DBV Technologies Food Allergies VIASKIN Patch
PRESS RELEASE published on 03/04/2026 at 22:30, 1 month 25 days ago DBV Technologies to Participate in Upcoming March Investor Conferences DBV Technologies to participate in upcoming investor conferences to present its late-stage biopharmaceutical developments for food allergies. Company uses proprietary VIASKIN patch technology for treatment Investor Conferences Biopharmaceutical DBV Technologies Food Allergies VIASKIN Patch
BRIEF published on 03/03/2026 at 22:35, 1 month 26 days ago DBV Technologies: February 2026 Voting Rights and Shares Update Voting Rights Shares DBV Technologies NYSE Euronext Paris February 2026
BRIEF published on 03/03/2026 at 22:35, 1 month 26 days ago DBV Technologies: Update on voting rights and shares Euronext Paris Share Capital Voting Rights Financial Regulations DBV Technologies
PRESS RELEASE published on 03/03/2026 at 22:30, 1 month 26 days ago Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 Important update on total voting rights and shares as of February 28, 2026 for NYSE Euronext Paris. Total gross voting rights: 278,352,082 Shares Total Voting Rights Regulations NYSE Euronext Paris February 28 2026
BRIEF published on 03/02/2026 at 15:53, 1 month 28 days ago JP Morgan's investment in DBV Technologies reaches new thresholds Crossing Thresholds Equity Swaps Shares And Voting Rights DBV Technologies JP Morgan
BRIEF published on 02/28/2026 at 20:30, 2 months 1 day ago DBV Technologies Unveils Promising Phase 3 VITESSE Study Results at AAAAI 2026 DBV Technologies Phase 3 Results Viaskin Peanut Patch Peanut Allergy Treatment VITESSE Study
Published on 04/30/2026 at 16:00, 1 hour 28 minutes ago CORRECTION FROM SOURCE: Rio Grande Resources Announces Results from its Airborne Survey at Winston Gold/Silver Project, New Mexico and Announces New President
Published on 04/30/2026 at 15:35, 1 hour 53 minutes ago Nepra Foods Enters Letter of Intent to Acquire Idaho Bottling and Water Assets, Advancing Vertical Integration Strategy
Published on 04/30/2026 at 15:10, 2 hours 18 minutes ago Formation Metals Announces Non-Brokered Offering of up to $15 Million Fully Allocated
Published on 04/30/2026 at 15:00, 2 hours 28 minutes ago Wi2Wi Corporation Announces Grant of Options
Published on 04/30/2026 at 15:00, 2 hours 28 minutes ago Karbon-X Advances Sur del Meta REDD+ Project with Biodiversity Partnership
Published on 04/30/2026 at 17:02, 25 minutes ago Verve announces the publication of its Annual and Sustainability Report for 2025
Published on 04/30/2026 at 16:33, 54 minutes ago Annual Report and Audited Accounts to 31 December 2025
Published on 04/30/2026 at 16:30, 58 minutes ago SoftwareOne publishes agenda for ordinary Annual General Meeting
Published on 04/30/2026 at 07:45, 9 hours 43 minutes ago The Belgian State and ENGIE Group enter into exclusive negotiations for the acquisition by Belgium of ENGIE's nuclear activities
Published on 04/30/2026 at 07:30, 9 hours 58 minutes ago New Gimv Anchor investment: acquisition of 5% shareholding in Azelis